Access to clinical expertise vital for life science firm BioClavis: Harper VanSteenhouse, President, BioClavis

Date08 Feb 2022

LocationLive Online Event: UK Timezone,

EventInvesting in Health Tech and Precision Medicine

All reports from this event here

related media

All presentations All videos

Laboratory boosts Glasgow’s life science infrastructure: Carol Clugston, Dean of Corporate Engagement & Innovation, University of Glasgow

Carol Clugston, Director,...

Precision medicine’s data needs could trap landlords: James Sheppard, Head of Commercial UK & Ireland, Kadans Science Partner

James Sheppard, Head of...

Networking and size attract life science innovators to Scotland: Marian McNeil, CEO, Precision Medicine Scotland Innovation Centre

Marian McNeil, CEO Precision...

Scottish government pushing “hugely important” life sciences: Ivan McKee MSP, Minister for Trade, Investment and Innovation, Scottish Government

Ivan McKee MSP, Minister for...

Investing in Health Tech and Precision Medicine – ON DEMAND – Full Event, February 2022

Investing in Health Tech & Precision Medicine – Living Laboratory Presentation – ON DEMAND

Carol Clugston, Director,...

Investing in Health Tech & Precision Medicine – ON DEMAND – Panel, Feb 2022

Upcoming events

Nov 17

Netherlands Leadership Meet-up

Dec 03

European Debt Finance & Investment Briefing

Dec 10

European Outlook 2027 – France

Apr 27

Transport Logistic 2027: Logistics Real Estate 2030 – How Location Shapes the Future of Transport Logistics